NCT02795351View on ClinicalTrials.gov

Induction of Migraine Aura With Sildenafil

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

February 28, 2021

Study Completion Date

August 31, 2021

Conditions
Migraine With Aura
Interventions
DRUG

Sildenafil

Single oral administration of active or placebo one week apart

DRUG

Placebo

Trial Locations (1)

2730

Department of Neurology, Herlev-Gentofte Hospital, Herlev

All Listed Sponsors
lead

Herlev Hospital

OTHER

NCT02795351 - Induction of Migraine Aura With Sildenafil | Biotech Hunter | Biotech Hunter